期刊文献+

前列腺电切术后的腹膜外腹腔镜下前列腺癌根治术(附18例报告) 被引量:6

Extraperitoneal laparoscopic radical prostatectomy after previous transurethral resection of prostate: Report of 18 cases
原文传递
导出
摘要 目的介绍对于经尿道前列腺电切术后(TURP)病理确诊为前列腺癌的患者,采用腹膜外腹腔镜下前列腺癌根治术(ELRP)治疗的经验。方法回顾性分析2006年12月至2012年10月18例TURP后在我科接受ELRP患者的临床资料。患者随访时间为2-72个月,分析术中出血量、术后尿管平均留置时间、并发症、尿控及肿瘤控制情况。结果所有病例术中均行淋巴结清扫。术中平均出血量为(328±102)ml,术后尿管平均留置时间为(12.4±8.7)d。所有病例前列腺切缘均为阴性。术后随访未发现肿瘤复发和远处转移。4例患者术后每日需使用1-2块尿垫,其余患者排尿可控,无需尿垫。术后性功能恢复率约为31%。结论 ELRP是治疗TURP术后的前列腺癌患者有效安全的手术方法。术后患者的肿瘤根治效果及尿控情况满意。TURP术后造成的炎性反应和组织粘连将会增加ELRP的手术难度。 Objective To describe our experiences on extraperitoneal laparoscopic radical prostatectomy(ELRP) for patients treated with transurethral resection of prostate (TURP) previously. Methods The clinical data of 18 patients who underwent ELRP after previous TURP between December 2006 and October 2012 at our hospital were retrospectively analyzed. All patients were followed-up about 2-72 months. Patients’ mean blood loss, mean catheterization time, complications, functional and oncologic outcome were comparatively reviewed. Results Lymphadenectomy was performed for all patients during operation .Mean blood loss was (328±102)ml, mean catheterization time was (12.4±8.7)days. No case had PSM. No tumor recurrence and distant metastasis occurred.Four patients needed 1-2 pads per day after operation and the others were of urinary continence. 31%of patients reported the ability to engage in sexual intercourse after operation. Conclusion ELRP is an effective treatment for patients with prostate cancer who underwent previous TURP. It can be safely performed without compromising functional and oncology results. ELRP for patients treated with previous TURP is more difficult in technical performing than for patients withno TURP treatment.
出处 《中国男科学杂志》 CAS CSCD 北大核心 2013年第5期34-37,共4页 Chinese Journal of Andrology
关键词 经尿道前列腺切除术 前列腺肿瘤 腹腔镜检查 transurethral resection of prostate prostatic neoplasms laparoscopy
  • 相关文献

参考文献14

  • 1王刚,周利群,那彦群.良性前列腺增生术后前列腺偶发癌10年回顾性分析[J].中华泌尿外科杂志,2005,26(2):117-120. 被引量:38
  • 2李素侠,王业勇,任萍.前列腺偶发癌病理分级与患者生存期的观察[J].中国肿瘤临床,2008,35(2):68-70. 被引量:3
  • 3Griffin JG, Holzbeierlein JM. Radical prostatectomy does not improve survival compared to observation for localised prostate cancer in a prospective randomised tfial.EvidBasedMed2012; doi: 10.1136/eb-2012-100994.
  • 4Hegarty J, Beirne PV, Walsh E, etal. Radical prostatectomy versus watchful waiting for prostate cancer. Cochraae Database SystRev 2010; (11): CD006590. doi: 10.1002/14651858.CD006590.
  • 5Ramon J, Rossignol G, Leandri P, et al. Morbidity of radical retropubic prostatectomy following previous prostate resection. JSurg Oncol 1994; 55(1): 14-19.
  • 6孙颖浩,高旭,许传亮,侯建国,王林辉,高小峰,廖国强.前列腺电切术后的前列腺癌根治术[J].中华泌尿外科杂志,2004,25(8):540-542. 被引量:15
  • 7Do M, Haefner T, Liatsikos E, et al. Endoscopic extraperitoneal radical prostatectomy after previous transurethral resection of prostate: Oncologic and functional outcomes of 100 cases. Urology2010; 75(6): 1348-1352.
  • 8Zugor V, Labanaris AP, Porres D, etal. Surgical, oncologic, and short-term functional outcomes in patients undergoing robot-assisted prostatectomy after previous transurethral resection of the prostate. JEndourol 2012; 26(5): 515-519.
  • 9Colombo R, Naspro R Salonia A, etal. Radical prostatectomy after previous prostate surgery: clinical and functional outcomes. J Urol 2006; 176(6 Pt 1): 2459-2463.
  • 10Menard J, de la Taille A, Hoznek A, et al. Comparison of laparoscopic radical prostatectomy with and without previous transurethral prostate surgery. Urology 2008; 72(3): 593-597.

二级参考文献28

共引文献45

同被引文献41

  • 1孙颖浩,高旭,许传亮,侯建国,王林辉,高小峰,廖国强.前列腺电切术后的前列腺癌根治术[J].中华泌尿外科杂志,2004,25(8):540-542. 被引量:15
  • 2Bellone M, Ceccon M, Grioni M, et al. iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T ceils [J]. PLoS One, 2010, 5(1): e8646.
  • 3Liu G, Lu S, Wang X, et al. Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis [J]. J Clin Invest, 2013, 123(10): 4410-4422.
  • 4Rafiei S, Komarova SV. Molecular signaling pathways mediating osteoclastogenesis induced by prostate cancer cells [J]. BMC Cancer, 2013, 13: 605.
  • 5Chugh S, Anand V, Swaroop L, et al. Involvement of Thl7 cells in patients of urothelial carcinoma of bladder [ J ]. Hum Immunol, 2013, 74(10) : 1258-1262.
  • 6Schwemmer B. Natural killer T cells in patients with prostatic carcinoma [J]. Urol Int, 2013, 71(2) : 146-149.
  • 7Shen L, Ciesielski M, Ramakrishnan S, et al. Class I histone deacetylase inhibitor entinostat suppresses regulatory T cells and enhances immunotherapies in renal and prostate cancer models [J]. PLoS One, 2012, 7(1): e30815.
  • 8Davidsson S, Ohlson AL, Andersson SO, et al. CD4helper T cells, CD8 cytotoxic T cells, and FOXP3 (+) regulatory T ceils with respect to lethal prostate cancer [J]. Mod Pathol, 2013, 26(3): 448-455.
  • 9SchuesslerW W. Kavoussi LR,Claymaa RV. Et al. Laparo-scopic radical prostatectomy:initial case report [J]. J Urol, 1992,147(Suppl) : 246A.
  • 10Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008 [J].C& cancer in China;a multieenter report of 6 institutions [J]. J Urol, 2005,174 (5) : 1794-1797.

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部